EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
Merck
Staff Engineer, Manufacturing Science and Technology, South East Asia
Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshooting and technical training for downstream processes Chan holds a degree in Chemical Engineering from the National University of Singapore
Articles
Multi-Target Directed Ligands and Lipidomics Approach for Glioblastoma Drug Discovery
The traditional pharmaceutical approach of designing a diseasesymptomspecific drug has historically proven effective However this methodology often falls short due to the complex and often multifactorial etiology of diseases
Research Insights
Radiation Necrosis after Radiation Therapy Treatment of Brain Metastases: A Computational Approach
Brain metastases are the most common intracranial malignancies in adults with around of patients with cancer developing brain metastases during the course of their diseases Most BMs originate from primary cancers from lung
Case Studies
Tablet Coating at Low Bed Temperatures with a Novel Coating Polymer
This study shows how to obtain elegant uniform coatings with zero visible defects and a practical coating solution for heat sensitive products For More Infromation Click Here
Techno Trends
UIC's Scientists Develop a Novel Device to Screen Advanced Crystalline Materials
Researchers and scientists at the University of Illinois at Chicago and AbbVie Inc developed a novel device to screen and test formation of drug substanceActive Pharmaceutical Ingredient API
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Pharma Regulatory Bottlenecks and Vaccination Delays
Sonam Chandwani is the Managing Partner at KS Legal & Associates. Her experience encompasses commercial and crosses border transactions across various sectors, advising both Indian companies in their outbound investments and foreign companies investing in India, on diverse areas of Indian laws concerning Mergers & Acquisitions, Insolvency & Bankruptcy, Banking & Finance, Real Estate, Arbitration and Litigation in Courts and Tribunals on a PAN-India basis.
The Emergence of Organ-on-chips for Diseases Studies and Drug Development
Giuseppe Maruccio is Full Professor at Department of Mathematics and Physics – University of Salento and head of Omnics Research Group which comprises researchers with different backgrounds from physics to life sciences working in cross-disciplinary areas with applications from -onics (electronics, spintronics and magnonics) to -omics technologies (genomics, proteomics and cellomics)
Anna Grazia Monteduro is researcher at Department of Mathematics and Physics - University of Salento in Lecce (Italy) and carries out her research activity within Omnics Research Group in the fields of (i) sensors, lab on chip and organ on chip; (ii) Nanoelectronics, spintronics, nanomagnetism and applied superconductivity.
Silvia Rizzato is researcher at the Department of Mathematics and Physics - University of Salento and carries out her research activity within Omnics Research Group on the development of new devices and processes for sensing and spintronics, including surface acoustic waves devices, electrochemical sensors and colloidal lithography for LSPR sensors.
Giusi Caragnano is a PhD student in Nanotechnologies at the University of Salento - CNR Nanotec and she is part of the Omnics Research Group. Her research activity concerns development of the Organ-on-chip to support the treatment of both chronic and cancerous gastrointestinal diseases
Current Research on Plant miRNA and Its Application in Disease Prevention
Atiya Saiyed is a Ph D student at Iladevi Cataract and IOL Research Centre and registered at Manipal Academy of Higher Education, Manipal. She is Senior Research Fellow from Indian Council of Medical Research, New Delhi. Atiya does research in the fields of molecular biology, cell biology, and cancer biology.
Abhay R. Vasavada is a well-known ophthalmologist who founded Raghudeep Eye Clinic (REH) and Iladevi Cataract and IOL Research Centre (ICIRC) in Ahmedabad, India. In 2011, the American Society of Cataract and Refractive Surgeons (ASCRS) gave him the Binkhorst Medal Lecture, making him the first Indian and just the second Asian to get the honour. He has almost 140 publications to his credit.
Kaid Johar SR is an Associate Professor in Department of Zoology and Biomedical TechnologyGujarat University, who specialized in cell and molecular biology, ophthalmology, cancer, and toxicology. He has almost 50 publications in prestigious journals.
Nanovaccines
Dr. Priya Gupta is currently working as an Assistant Professor at Amity Institute of Pharmacy, Amity University, Noida and earned her Ph.D. in Pharmaceutics from Jamia Hamdard in 2024. Her area of research includes formulation development, novel drug delivery systems, nanoformulations. She has authored more than 15 articles in peer-reviewed national and international journals.
Dr. Disha Marwaha earned a Ph.D. in Biological Sciences from the CSIR-Central Drug Research Institute (CSIR-CDRI) in 2024 and currently serves as an Assistant Professor at Chandigarh University Uttar Pradesh. Her research encompasses nanomedicine, pharmacokinetics, formulation development, and targeted drug delivery systems. She has authored more than 22 articles in peer-reviewed international journals.
press releasesRead more...
Insitro Designed Machine Learning Models for Small Molecule in vivo Pharmacokinetic Behavior Prediction Now Available in Lilly TuneLab
Insitro the AI company unlocking causal human biology to systematically generate highimpact therapeutics today announced that the advanced machine learning models that insitro built with Eli Lilly
Lotus Pharmaceutical Announces Completion of UroVaxom® Product Rights Acquisition in South Korea
Lotus Pharmaceutical Co Ltd Taiwan Stock Exchange a global pharmaceutical company headquartered in Taiwan today announced the completion of the acquisition of the South Korea product rights
XtalPi Debuts Kodexia™, the World's First Closed-Loop siRNA Platform Combining Generative AI with First-Principles Modeling
XtalPi Holdings Limited HKEX an AI and roboticsdriven drug and materials discovery company today debuted Kodexia the industrys first closedloop small interfering RNA siRNA
ITOCHU Announces Strengthening of Drug Development Support Through the Use of AI-Driven Drug Discovery Technologies
ITOCHU Corporation announced today that it has signed a capital alliance agreement with MOLCURE Inc headquartered in Kawasaki City Kanagawa Prefecture Satoshi Tamaki Representative Director
GC Cell and QuantHealth Collaborate to Optimize Clinical Development of GCC2005
GC Cell a leader in the cell and gene therapy CGT sector within the biopharmaceutical industry and QuantHealth the global leader in AIpowered clinical trial simulation have announced a collaboratio
EpiSign and Geneyx Announce Partnership to Integrate Genomic and Epigenomic Analysis for Rare Disease
EpiSign Inc and Geneyx Genomex Ltd today announced a partnership to advance the integration of genomic and epigenomic analysis for raredisease interpretation
EventsRead more...
12 - 13
Oct 2026Pharmaceutics 2026
Village Hotel Changi, Singapor...
12 - 13
Oct 20262nd International Conference on Drug Discovery
Village Hotel Changi, Singapor...
14 - 15
Oct 2026PDA Aseptic Manufacturing Excellence Conference
Pullman East Melbourne, Austra...
21 - 23
Oct 2026Drug Formulation & Drug Delivery 2026
Paris, France
21 - 22
Oct 2026Advance Clinical Trials and Research 2026
Paris, France
22 - 23
Oct 2026PDA Aseptic Symposium 2026
Congress Square Nakanoshima, O...
26 - 28
Oct 2026ACHEMA Middle East 2026
RICEC, Riyadh, KSA, Saudi Arab...
26 - 28
Oct 2026World Orphan Drug Congress
RAI, Amsterdam, Netherlands
LATEST NEWSRead more...
Mint Pharmaceuticals and Bayer Expand Medicine Distribution in Canada
Mint Pharmaceuticals and Bayer have expanded their distribution partnership in Canada to include several additional medicines across womens health cardiovascular care and anticoagulation
Halozyme Expands argenx Collaboration to Include Two Additional Development Targets
Halozyme Therapeutics has expanded its global collaboration and licence agreement with argenx to develop and commercialise subcutaneous formulations for two additional exclusive targets using its ENHANZE drug delivery technology
CSL and Alentis Partner to Advance Lixudebart for Rare Kidney and Liver Diseases
CSL and Alentis Therapeutics have entered into a global collaboration to jointly develop and commercialise lixudebart an investigational treatment that targets claudin and could have applications across several kidney liver and other diseases
Regeneron and Sanofi Expand Collaboration to Develop Long-Acting Immunology Antibodies
Regeneron Pharmaceuticals and Sanofi have expanded their longstanding antibody collaboration to develop and commercialise a new group of longacting immunology treatments
SK pharmteco Announces $200 Million Investment to Expand Manufacturing Capacity
SK pharmteco has announced a fiveyear investment of more than million to expand and upgrade its development and manufacturing capabilities in the US focusing on small molecules and peptides
CAS and Novartis Collaborate to Advance AI-Ready Reaction Data
CAS has announced a collaboration with Novartis Biomedical Research to improve access to reaction data and support the use of artificial intelligence in scientific research